Abbott Laboratories moves brief for arthritis drug Humira to Luther Pendragon
Abbott Laboratories has ditched Weber Shandwick and brought in Luther Pendragon for a lucrative external affairs account for one of its most profitable drugs.

Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>